Offer - Urjas Oil for just ₹ 1 X
Telfirst CT 40 Mg/6.25 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telfirst CT 40 Mg/6.25 Mg Tablet safe for pregnant women?
Telfirst CT has mild to no side effects in pregnant women.
Is the use of Telfirst CT 40 Mg/6.25 Mg Tablet safe during breastfeeding?
Side effects of Telfirst CT for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Telfirst CT 40 Mg/6.25 Mg Tablet on the Kidneys?
Telfirst CT has very mild side effects on the kidneys.
What is the effect of Telfirst CT 40 Mg/6.25 Mg Tablet on the Liver?
Telfirst CT is rarely harmful for the liver.
What is the effect of Telfirst CT 40 Mg/6.25 Mg Tablet on the Heart?
Telfirst CT may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Telfirst CT 40 Mg/6.25 Mg Tablet unless your doctor advises you to do so -
Is this Telfirst CT 40 Mg/6.25 Mg Tablet habit forming or addictive?
No, there is no any evidence that Telfirst CT 40 Mg/6.25 Mg Tablet is addictive.
Interaction between Food and Telfirst CT 40 Mg/6.25 Mg Tablet
Eating certain foods may increase the time it takes Telfirst CT 40 Mg/6.25 Mg Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Telfirst CT 40 Mg/6.25 Mg Tablet
Taking alcohol with Telfirst CT 40 Mg/6.25 Mg Tablet can be dangerous.
No, Telfirst CT does not cause weight gain. Weight gain has rarely been associated with this drug. However, if you are experiencing unusual weight gain and you are in doubt that Telfirst CT is causing weight gain then discuss with your doctor instantly.
No, Telfirst CT is not bad for kidneys. In fact, it protects the kidneys, thus, it is suitable for people with diabetes and mild-to-moderate kidney disease.
Telfirst CT is the brand name for telmisartan. It belongs to a group of medications known as angiotensin II receptor blockers. It is available in the form of tablets. Telfirst CT is used to treat hypertension. It is also used to decrease cardiovascular risk in patients who cannot take ACE (angiotensin-converting enzyme) inhibitors.
Yes, Telfirst CT may cause a cough on rare occasions. If you experience a cough while taking Telfirst CT, please talk to your doctor immediately.
Telfirst CT is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Telfirst CT might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Telfirst CT exactly as prescribed by their doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448